Fetal erythroblastosis
MONDO:0006760A disorder of the fetus or newborn that occurs when fetal cells that are coated with IgG alloantibodies from the mother attack antigens inherited from the father. Severity can range from absence of symptoms to death.
Also known as: HDFN, erythroblastosis fetalis, hemolytic disease of the fetus or newborn, hemolytic disease of the foetus or newborn, hemolytic disease of the newborn, isoimmune hemolytic disease of the newborn
16 clinical trials for this condition and its sub-types, 7 tagged with Fetal erythroblastosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New drug shows promise for preventing severe anemia in unborn babies
Disease control CompletedThis study tested an experimental drug called M281 (nipocalimab) in 25 pregnant women at high risk for early-onset severe hemolytic disease of the fetus and newborn (HDFN), a condition where the mother's immune system attacks the baby's red blood cells. The goal was to see if the…
Phase 2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study tracks High-Risk pregnancies to improve newborn health
Knowledge-focused CompletedThis study followed 17 pregnant women and their babies who were at high risk for early onset severe hemolytic disease of the fetus and newborn (EOS-HDFN). The goal was to see how the condition is currently managed and what outcomes occur. No new drugs were tested; instead, resear…
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:16 UTC